Evidence map›Paper›PMID 19912231›Full record

ArticleBritish journal of pharmacology2009

Glucocorticoid-stimulated, transcription-independent release of annexin A1 by cochlear Hensen cells.

F Kalinec, P Webster, A Maricle, D Guerrero, D N Chakravarti, B Chakravarti, R Gellibolian, G Kalinec

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. The role and application prospects of ANXA1 in gastric cancer cells.Medical oncology (Northwood, London, England) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Purinergic Signaling and Cochlear Injury-Targeting the Immune System?International journal of molecular sciences · 2019
    Review
  12. Article
  13. A Polymer-Based Extended Release System for Stable, Long-term Intracochlear Drug Delivery.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2018
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

F KalinecDivision of Cell Biology and Genetics, House Ear Institute, Los Angeles, CA 90057, USA. fkalinec@hei.org
P Webster
A Maricle
D Guerrero
D N Chakravarti
B Chakravarti
R Gellibolian
G Kalinec
House Clinic · USUniversity of Southern California · USClaremont Colleges · US

Funding

Imaging CoreP30DC006276 · NIDCD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EISENBERG, LAURIE S · 2003 to 2016
$3.9M
Regulation of Inflammatory Responses in the CochleaR01DC010397 · NIDCD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KALINEC, FEDERICO · 2010 to 2014
$1.8M
NIDCD NIH HHS P-30 DC006276NIDCD NIH HHS P30 DC006276NIDCD NIH HHS R01 DC010397
6 · The paper itself

Abstract

background and purposeThe current clinical strategy to protect the auditory organ against inflammatory damage by migrating leukocytes is the local delivery of glucocorticoids. However, the mechanism by which glucocorticoids confer this protection remains unknown. Therefore, we investigated the cellular and molecular targets of glucocorticoids in the cochlea that could be involved in preventing leukocyte migration. EXPERIMENTAL APPROACH: We used microscopy as well as immunocytochemical and microfluidic techniques to elucidate the effect of dexamethasone, hydrocortisone and prednisolone on the cellular and intracellular distribution of annexin A1 (ANXA1) - a glucocorticoid target known to inhibit leukocyte migration by receptor-mediated signalling - in the cochlea and isolated cochlear cells of guinea pigs. KEY

resultsAll the cells lining the scala media - the cochlear compartment containing the auditory organ - express ANXA1 and the ANXA1 receptor FPR2/ALX is present in the scala media, as well as in other cochlear ducts. The majority of ANXA1 in the scala media is stored inside lipid droplets within cochlear Hensen cells. Glucocorticoids activate a myosin IIC-mediated mechanism that drives ANXA1 from the lipid droplets to the apical region of the Hensen cells, where ANXA1 is released to the external milieu by a process involving ABC transporters. CONCLUSIONS AND IMPLICATIONS: These findings suggest that ANXA1 could be a major mediator of the anti-inflammatory effects of glucocorticoids in the cochlea and identify new molecular targets for prevention of sudden sensorineural hearing loss.

Indexed as

AnimalsAnnexin A1CochleaDexamethasoneDrug Delivery SystemsGlucocorticoidsGuinea PigsHydrocortisoneMicroscopyMyosin Type IIPrednisoloneReceptors, Formyl PeptideSignal TransductionAnnexin A1DexamethasoneGlucocorticoidsHydrocortisoneMyosin Type IIPrednisoloneReceptors, Formyl Peptide

Identifiers

PMID19912231
PMCPMC2801223
OpenAlexW1594205667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.